Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Indoco Remedies Limited ( (IN:INDOCO) ).
Indoco Remedies Limited has entered into a sale and leaseback agreement for part of its movable properties at the Waluj Facility and AnaCipher Clinical Research Organisation. This strategic move, involving OPC Asset Solution Pvt. Ltd, allows Indoco to continue using these assets without impacting its manufacturing or business operations, ensuring operational continuity while optimizing financial resources.
More about Indoco Remedies Limited
Indoco Remedies Limited operates in the pharmaceutical industry, focusing on the development, manufacture, and marketing of pharmaceutical products. The company is known for its wide range of formulations and active pharmaceutical ingredients (APIs), catering to both domestic and international markets.
Average Trading Volume: 5,121
Technical Sentiment Signal: Sell
Current Market Cap: 25.34B INR
For a thorough assessment of INDOCO stock, go to TipRanks’ Stock Analysis page.